Objective: To determine the prevalence of primary hyperhidrosis in the city of Botucatu, Brazil, and to evaluate how this disorder affects the quality of life in those suffering from it.
Methods: A population survey was conducted in order to identify cases of hyperhidrosis among residents in the urban area of the city, selected by systematic cluster sampling. In accordance with the census maps of the city, the sample size should be at least 4,033 participants. Ten interviewers applied a questionnaire that evaluated the presence of excessive sweating and invited the subjects who reported hyperhidrosis to be evaluated by a physician in order to confirm the diagnosis.
Results: A total of 4,133 residents, in 1,351 households, were surveyed. Excessive sweating was reported by 85 residents (prevalence = 2.07%), of whom 51 (60%) were female. Of those 85 respondents, 51 (60%) agreed to undergo medical evaluation to confirm the diagnosis and only 23 (45%) were diagnosed with primary hyperhidrosis (prevalence = 0.93%). Of the 23 subjects diagnosed with primary hyperhidrosis, 11 (48%) reported poor or very poor quality of life.
Conclusions: Although the prevalence of self-reported excessive sweating was greater than 2%, the actual prevalence of primary hyperhidrosis in our sample was 0.93% and nearly 50% of the respondents with primary hyperhidrosis reported impaired quality of life.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6326708 | PMC |
http://dx.doi.org/10.1590/S1806-37562017000000379 | DOI Listing |
Cureus
November 2024
Department of Cardiothoracic Surgery, Alexandria University, Alexandria, EGY.
Introduction: Primary hyperhidrosis is a disease that is characterized by excessive sweating beyond what is required to maintain the normal temperature of the body. Moreover, it has a great adverse effect on the life of the affected persons because of problems in their social lives. There are different modalities to treat primary hyperhidrosis, including medical and surgical treatment.
View Article and Find Full Text PDFJ Dermatolog Treat
December 2025
Faculty of Medicine, University of Kalamoon, Al_Nabk, Syria.
Background: Primary axillary hyperhidrosis has limited noninvasive and effective treatment, and we present the use of sofpironium bromide as a promising treatment option. We aimed to assess the efficacy and safety of sofpironium in patients with primary hyperhidrosis.
Methods: We systematically searched the databases for Studies that assessed sofpironium bromide in patients with primary axillary hyperhidrosis.
Einstein (Sao Paulo)
December 2024
Department of Clinical Analysis, Universidade Federal de Santa Catarina, Florianópolis, SC, Brazil.
Clin Ther
December 2024
Pharmacy department, Affiliated Banan Hospital of Chongqing Medical University, Chongqing, China.
J Minim Access Surg
November 2024
Department of Thoracic Surgery, Trakya University Faculty of Medicine, Edirne, Turkey.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!